Suchergebnisse

Overview of the criminal justice system / Charles L. Scott -- Criminal justice system and offenders placed in an outpatient setting / Erik Roskes ... [et al.] -- Legal issues regarding the provision of care in a correctional setting / Charles L. Scott -- The mental health professional in a correctional culture / Kenneth L. Appelbaum -- Conducting mental health assessments in correctional settings / Humberto Temporini -- Continuous quality improvement and documentation / Amanda Ruiz -- Evaluating and treating substance use disorders / Tracy D. Gunter -- Managing disruptive and aggressive inmates / Steven J. Helfand -- Suicide prevention in correctional facilities / Lindsay M. Hayes -- Assessment of malingering in correctional settings / Michael J. Vitacco, Richard Rogers -- Trauma and incarcerated persons / Nancy Wolff, Jing Shi -- Psychopharmacology / Kathryn A. Burns -- Creating wellness through collaborative mental health interventions / Shama B. Chaiken, Catherine Prudhomme --

Intro -- PHARMACEUTICAL INNOVATIONCHALLENGES AND COMPETITORS -- PHARMACEUTICAL INNOVATIONCHALLENGES AND COMPETITORS -- CONTENTS -- Preface -- Chapter 1 - Drug Patent Expirations:Potential Effects on Pharmaceutical Innovation( -- Summary -- Introduction -- The Pharmaceutical Industry -- Role of Patents -- The Hatch-Waxman Act -- Patent Expirations -- Innovation Issues -- Blockbuster Drugs and the Innovation Pipeline -- Drug Approvals -- Productivity Issues -- Concluding Observations -- End Notes -- Chapter 2 - Authorized Generic Pharmaceuticals: Effects on Innovation -- Summary -- Marketing Approval and Patent Issues for Generic Drugs -- FDA Approval Procedures -- Resolution of Patent Disputes -- Generic Marketing Exclusivity -- The Concept of Authorized Generics -- Authorized Generics Practice -- Authorized Generics within the Hatch-Waxman Framework -- Legality of Authorized Generics -- Concluding Observations -- End Notes -- Chapter 3 - Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation -- Summary -- Patent Disputes under the Hatch-Waxman Act -- Patent Fundamentals -- FDA Approval Procedures -- Resolution of Patent Disputes -- Generic Exclusivity -- Fundamentals of Reverse Payment Settlements -- Antitrust Implications of Reverse -- Payment Settlements -- Sixth Circuit -- Eleventh Circuit -- Second Circuit -- Federal Circuit -- Issues and Observations -- End Notes -- Chapter 4 - The Hatch-Waxman Act: A Quarter Century Later -- Summary -- Introduction -- Overview of the Original Act -- Accelerated Generic Drug Approval Process -- Patent Term Restoration -- Data Exclusivity -- Amendments: The Medicare Prescription Drug and Modernization Act of 2003 -- Implementation -- Selected Issues -- Authorized Generics59 -- Patent Settlements76 -- Follow-On Biologics82 -- Concluding Observations -- End Notes